Reduction in epidermal Langerhans cells in patients with necrolytic migratory erythema

Journal of Dermatological Science

Volumn 50, Issue 1, 2008, Pages 76-80

  Rokunohe, Daiki ^a   Nakano, Hajime ^a   Ikenaga, Satsuki ^a   Umegaki, Noriko ^a   Kaneko, Takahide ^a   Matsuhashi, Yuki ^b   Tando, Yusuke ^b   Toyoki, Yoshikazu ^b   Hakamada, Kenichi ^b   Kusumi, Tomomi ^a   Harada, Ken ^c   Sawamura, Daisuke ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Amino acid deficiency; Langerhans cell; Necrolytic migratory erythema; Zinc deficiency

Indexed keywords

ADULT; AMYLOIDOSIS; CASE REPORT; CLINICAL EXAMINATION; CONTROLLED STUDY; ERYTHEMA; FEMALE; GLUCAGONOMA; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; LANGERHANS CELL; LETTER; MALE; NECROLYTIC MIGRATORY ERYTHEMA; NEUTROPHIL CHEMOTAXIS; PARAKERATOSIS; PRIORITY JOURNAL; PUSTULAR PSORIASIS; PUSTULE; SKIN BIOPSY; SKIN INFLAMMATION; SKIN MANIFESTATION;

ADULT; ANTIGENS, CD1; ERYTHEMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MALE; MIDDLE AGED;

EID: 39149118889     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.11.001     Document Type: Letter

References (9)

1. Mullans E.A., and Cohen P.R. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol 38 (1998) 866-873
2. Asahina A., and Tamaki K. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary?. J Dermatol Sci 44 (2006) 1-9
3. Chiyoya S., Hanada K., Hashimoto I., and Katabira Y. Influence of zinc deficiency on cell-mediated immunity. In: Brown S.S., and Kodama Y. (Eds). Toxicology of metals: clinical and experimental research (1987), Ellis Horwood Ltd., Chichester, UK 37-39
4. Grabbe S., Steinbrink K., Steinert M., Luger T.A., and Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155 (1995) 4207-4217
5. Baadsgaard O., Gupta A.K., Taylor R.S., Ellis C.N., Voorhees J.J., and Cooper K.D. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells. J Invest Dermatol 92 (1989) 190-195
6. Bieber T., and Braun-Falco O. Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions. Acta Derm Venereol 69 (1989) 175-178
7. Kawamura T., Furuhashi M., Nakano H., Hanada K., and Shimada S. Complete loss of Langerhans cells in the lesional skin in acrodermatitis enteropathica with novel SLC39A4 mutation. J Invest Dermatol 126 Suppl. 3 (2006) s95 (abstract)
8. Fan Q., Yee C.L., Ohyama M., Tock C., Zhang G., Darling T.N., et al. Bone marrow-derived keratinocytes are not detected in normal skin and only rarely detected in wounded skin in two different murine models. Exp Hematol 34 (2006) 672-679
9. Glick A.B., Lee M.M., Darwiche N., Kulkarni A.B., Karlsson S., and Yuspa S.H. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev 8 (1994) 2429-2440